Upregulation of enzymes metabolizing 5-fluorouracil in colorectal cancer

被引:15
|
作者
Matsusaka, Satoshi [1 ]
Yamasaki, Hajime [1 ]
Fukushima, Masakazu [1 ]
Wakabayashi, Ichiro [1 ]
机构
[1] Yamagata Univ, Sch Med, Dept Hyg & Prevent Med, Yamagata 9909585, Japan
关键词
colorectal cancer; 5-fluorouracil; lymph node metastasis; orotate phosphoribosyltransferase; ribonucleotide reductase;
D O I
10.1159/000098249
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The purpose of this study was to compare the activities of various enzymes, participating in the metabolism of 5-fluorouracil, between colorectal cancer and nontumor tissues and to investigate the association of the enzyme activities with clinicopathological backgrounds. Methods: Activities of seven enzymes involved in nucleic acid metabolism - orotate phosphoribosyltransferase (OPRT), ribonucleotide reductase (RNR), thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, uridine phosphorylase and thymidine kinase (TK) - were measured in tumor and nontumor tissues from 28 patients who were operated on for colorectal cancers. Results: OPRT, thymidylate synthase, RNR, thymidine phosphorylase, uridine phosphorylase and thymidine kinase activities were significantly higher in tumor areas than in nontumor areas. OPRT showed the highest T/N ratio ( the ratio of each enzyme activity in tumor areas to that in nontumor areas). The T/N ratio of RNR activity showed a tendency to be associated with lymph node metastasis and Dukes classification. Conclusion: The results suggest that OPRT is a main enzyme participating in the phosphorylation of 5-fluorouracil and has an important role in tumor growth. The T/N ratio of RNR may be predictive of tumor progression. Copyright (c) 2007 S. Karger AG, Basel
引用
收藏
页码:36 / 41
页数:6
相关论文
共 50 条
  • [21] Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis
    Mikito Inokuchi
    Hiroyuki Uetake
    Yoshinori Shirota
    Hiroyuki Yamada
    Masayuki Tajima
    Kenichi Sugihara
    Cancer Chemotherapy and Pharmacology, 2004, 53 : 391 - 396
  • [22] PHARMACOKINETICS OF 5-FLUOROURACIL IN COLORECTAL-CANCER PATIENTS RECEIVING INTERFERON
    PITTMAN, K
    PERREN, T
    WARD, U
    PRIMROSE, J
    SLEVIN, M
    PATEL, N
    SELBY, P
    ANNALS OF ONCOLOGY, 1993, 4 (06) : 515 - 516
  • [23] ACTIVITY OF CONTINUOUS-INFUSION 5-FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CANCER CLINICALLY RESISTANT TO BOLUS 5-FLUOROURACIL
    MORI, A
    BERTOGLIO, S
    GUGLIELMI, A
    ASCHELE, C
    BOLLI, E
    TIXI, L
    ROSSO, R
    SOBRERO, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 33 (02) : 179 - 180
  • [24] 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
    Vodenkova, Sona
    Buchler, Tomas
    Cervena, Klara
    Veskrnova, Veronika
    Vodicka, Pavel
    Vymetalkova, Veronika
    PHARMACOLOGY & THERAPEUTICS, 2020, 206
  • [25] MicroRNAs and drug resistance in colorectal cancer with special focus on 5-fluorouracil
    Pouya, Fahima Danesh
    Gazouli, Maria
    Rasmi, Yousef
    Lampropoulou, Dimitra Ioanna
    Nemati, Mohadeseh
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (06) : 5165 - 5178
  • [26] Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update
    Pan Xie
    Jun-Luan Mo
    Jin-Hong Liu
    Xi Li
    Li-Ming Tan
    Wei Zhang
    Hong-Hao Zhou
    Zhao-Qian Liu
    Cellular Oncology, 2020, 43 : 989 - 1001
  • [27] 5-Fluorouracil induces apoptosis of colorectal cancer cells
    Zhang, J. T.
    Zhou, W. L.
    He, C.
    Liu, T.
    Li, C. Y.
    Wang, L.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (01)
  • [28] Relationship Between Gene Expression of 5-Fluorouracil Metabolic Enzymes and 5-Fluorouracil Sensitivity in Primary Cancer Cells Isolated from Malignant Ascites
    Wang, Tingting
    Wang, Lifeng
    Qian, Xiaoping
    Yu, Lixia
    Ding, Yitao
    Liu, Baorui
    CANCER INVESTIGATION, 2011, 29 (02) : 130 - 136
  • [29] Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer
    I Chau
    A Webb
    D Cunningham
    M Hill
    J S Waters
    A Norman
    A Massey
    British Journal of Cancer, 2001, 85 : 1258 - 1264
  • [30] Biochemical modulation of 5-fluorouracil with methotrexate in advanced colorectal cancer patients pretreated with adjuvant 5-fluorouracil and leucovorin
    Pronzato, P
    Vaira, F
    Vigani, A
    Losardo, P
    Bertelli, G
    ANTICANCER RESEARCH, 1995, 15 (6B) : 2679 - 2682